Complements strong initial data from LPS challenge trial and is in line with stated objective at IPO to expand POLB 001 to additional indications.
Poolbeg Pharma PLC (AIM:POLB) Positive Initial Data Analysis in POLB 001 Trial
Early data readout indicates a successful LPS human challenge trial
Poolbeg Pharma PLC (AIM:POLB) POLB 001 US Patent update
Continued expansion of IP portfolio enhancing protection of Poolbeg’s growing pipeline
Vela Technologies (AIM:VELA) Update re. St George Street Capital COVID-19 trial
The Board of Vela (AIM: VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, notes that St George Street Capital Ltd (“SGSC”), has today announced the
Credit Suisse Group AG Convicted for Historic Money Laundering
Cocaine, Cash, an unlucky Bulgarian wrestler, the lurid details of the February trial captured the attention of Swiss finance. Credit Suisse Group AG was accused of failing to stop a
Vela Technologies (AIM:VELA) Statement re. potential investment in TruSpine
The Board of Vela (AIM:VELA), an AIM-quoted investing company focused on early-stage and pre-IPO disruptive technology investments, announces that, on Friday 10 June 2022, the Company became aware of a
Tesla investors demand that a judge order Musk to repay $13 billion for the SolarCity deal
Tesla Inc (TSLA.O) shareholders asked a judge Tuesday to determine whether Elon Musk coerced its board into signing a 2016 SolarCity deal. They also requested that the chief executive be
Vela Technologies (VELA.L) Update re. St George Street Capital COVID-19 trial
Further to the update released by Vela on 9 September 2021, the Board of Vela (AIM: VELA) has been informed by St George Street Capital (“SGSC”) that the Clinical Study
Destiny Pharma PLC (DEST.L) Study gives strong support for potential of XF-73 & CEO Interview
Major US hospital-based clinical trial highlights benefit of nasal decolonization to reduce ICU infections caused by Staphylococcus aureus
Vela Technologies (VELA.L) Update re. Aeristech
The Board of Vela notes the announcement by Sprintex (ASX: SIX) of its collaboration agreement with Aeristech Limited (“Aeristech”) which will facilitate Sprintex’s penetration into the high-growth and lucrative hydrogen
Vela Technologies (VELA.L) Update re. St George Street Capital Holding
The Board of Vela is pleased to announce that the Company’s joint broker, Peterhouse Capital Limited, has today placed the entirety of St. George Street Capital’s (“SGSC”) 1,100,000,000 shares with